Request a Consultation
Our experts can help you reframe what’s possible.
Today’s access environment is increasingly complex. Payer expectations are evolving rapidly, and conventional assumptions around coverage, evidence, and approval criteria are no longer sufficient. Success requires more than compelling clinical data; it demands targeted strategy grounded in real-world stakeholder insights.
Acumetis Strategic Global Value and Access Insights Service empowers pharmaceutical manufacturers with the clarity to navigate the evolving access environment with confidence. We deliver insight-driven guidance by integrating perspectives from payers, PBMs, SPs, IDN decision makers, translating stakeholder expectations into meaningful access strategies.
We go beyond traditional market research to uncover what truly drives access decisions. Our methodology blends qualitative and quantitative research, secondary research, advanced analytics, and input from our proprietary Acumetis Advisor Network, a curated panel of 1,400+ vetted healthcare stakeholders.
This approach enables us to generate actionable insights that are both timely and strategically aligned. Whether preparing for launch, refining your value story, or adjusting to evolving payer dynamics, we provide the strategic foundation to move decisively.
Our global value and access insights service supports strategic decision points throughout the product lifecycle:
Through our Global Acumetis Advisor Network, we deliver access to the decision-makers shaping access strategy:
Engaging pharmacy, medical, and executive leaders across national, regional, and Blues plans—additionally, C-suite executives, quality directors and practice managers.
Connecting with key pharmacy, contracting, and medical stakeholders at top U.S. pharmacy benefit managers.
Reaching decision-makers across integrated delivery networks, including those with health plan components.
Partnering with health economists, payer experts, academic experts, and former HTA leaders to shape global access strategy.
Achieving global market access requires more than strong clinical data — it requires a value foundation that is strong enough to build on and flexible enough to adapt as markets evolve. We bring together integrated, multi-capability expertise to define where your asset demonstrates value, build the evidence that proves it, and communicate it in a way that achieves success and drives adoption. Built on 100+ economic models across 20+ countries, our consultants’ partner with you to de-risk the decisions that shape commercialization success for the widest patient population.
Whether preparing for launch, responding to shifting payer dynamics, or enhancing pull-through, Acumetis delivers strategic insight to unlock access and drive impact.
Our experts can help you reframe what’s possible.
"*" indicates required fields